US 7772434
Crystalline form of a β2 adrenergic receptor agonist
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7772434 (Crystalline form of a β2 adrenergic receptor agonist) held by Theravance, Inc. expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P11/08, A61P43/00